Blurbs

Analysts Are Bullish on These Healthcare Stocks: PDS Biotechnology (PDSB), BioSig Technologies (BSGM)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PDS Biotechnology (PDSBResearch Report) and BioSig Technologies (BSGMResearch Report) with bullish sentiments.

PDS Biotechnology (PDSB)

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on PDS Biotechnology, with a price target of $22.00. The company’s shares closed last Thursday at $6.19, close to its 52-week low of $4.10.

According to TipRanks.com, LeBoyer is a 4-star analyst with an average return of 19.4% and a 36.7% success rate. LeBoyer covers the Healthcare sector, focusing on stocks such as Lineage Cell Therapeutics, Ayala Pharmaceuticals, and Onconova Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for PDS Biotechnology with a $18.50 average price target, a 190.9% upside from current levels. In a report released yesterday, H.C. Wainwright also maintained a Buy rating on the stock with a $15.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

BioSig Technologies (BSGM)

Noble Financial analyst Gregory Aurand maintained a Buy rating on BioSig Technologies today and set a price target of $4.00. The company’s shares closed last Thursday at $1.15, close to its 52-week low of $0.90.

According to TipRanks.com, Aurand is ranked #7436 out of 7924 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for BioSig Technologies with a $4.00 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PDSB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos